AC
NKTR icon

Amia Capital’s Nektar Therapeutics NKTR Stock Holding History

Amia Capital’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-953
Closed -$237K – 23
2020
Q3 		$237K Sell
953
-29
-3% -$9.12K 0.28% 28
2020
Q2 		$341K Sell
982
-541
-36% -$169K 0.28% 26
2020
Q1 		$408K Sell
1,523
-279
-15% -$86.3K 0.36% 24
2019
Q4 		$583K Buy
+1,802
New +$523K 0.17% 30

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Amia Capital's NKTR Position: Q4 2020 in Review

Amia Capital sold out of Nektar Therapeutics (NKTR) in Q4 2020, closing a stake of 953 shares — an estimated $237K sold.

Amia Capital first reported a position in NKTR in Q4 2019 and held it in 4 quarters. The position peaked at $583K in Q4 2019. 245 funds tracked by Wall St. Rank hold NKTR as of Q4 2020.

  • Amia Capital reported no remaining Nektar Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Amia Capital sold 953 Nektar Therapeutics shares in Q4 2020, an estimated $237K.
  • Amia Capital first reported a position in Nektar Therapeutics in Q4 2019 and held it in 4 quarters.
  • Amia Capital's Nektar Therapeutics position peaked at $583K in Q4 2019.
  • 245 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2020.

Based on Amia Capital's 13F filing for Q4 2020, filed 11 Feb 2021.